Alopecia can be genetic and appear gradually over time or be triggered by hormonal changes, improper nutrition, or stress at any age. Androgenic alopecia is the most common type of hair loss. It can affect both men and women, but it is clearly more common in men and shows different patterns according to sex. Male pattern baldness shows a recession of the hairline in the temples and increasing hair fall in the crown of the head. For female pattern baldness, it begins as homogeneous hair weakening, and increased
shedding. However, as the problem evolves, both sexes present pronounced hair loss in the crown, and women’s hairline can also recede a little.
Hair loss occurs when new hair doesn’t replace the hair that has fallen out. It is typically related to one or more of the following factors:
Microneedling, particularly when used in combination with PRP (Platelet-Rich Plasma) and/or mesotherapy, offers a multi-faceted
approach to treating alopecia. The microinjuries created by imedpen® stimulates the release of growth factors and cytokines, which, when combined with concetrated PRP, promote vascularization to increase hair follicle size and volume, and stimulates hair growth. It also enhances angiogeneses, facilitating the development of a robust capillary network that nourishes hair follicles and delivers essential hormones for sustained hair health.